Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme announced on March 28, 2025.
Key Financial Metrics and Share Capital
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity and capital structure updates.
- Shares Purchased: 830,397 ordinary shares
- Purchase Date: May 9, 2025
- Price Range: 402.70p (Low) to 407.00p (High)
- Volume Weighted Average Price: 405.03p
- Post-Transaction Registered Capital: 9,016,724,418 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 9,012,644,213
Material Changes
The primary material change is the reduction of outstanding voting shares following the cancellation of 830,397 shares purchased on May 9, 2025. This action reduces the total number of shares with voting rights to 9,012,644,213.
Guidance, Outlook, and Risks
The filing contains no financial guidance, forward-looking outlook, management commentary on operations, or discussion of risks and contingencies. It is a regulatory disclosure of a specific share transaction.
Key Facts for Investor Verification
- Verify the total number of voting shares (9,012,644,213) for compliance with FCA Disclosure Guidance and Transparency Rules.
- Confirm the execution of the buyback programme initiated on March 28, 2025.
- Note that the filing does not contain financial performance data; refer to the company's website or Form 20-F for earnings and operational metrics.